Acetylsalicylic acid enhances antiproliferative effects of the EGFR inhibitor gefitinib in the absence of activating mutations in gastric cancer.
暂无分享,去创建一个
M. Stolte | T. Fujimori | L. Tickenbrock | H. Serve | C. Müller-Tidow | N. Tidow | C. Brandts | W. Domschke | T. Pohle | J. C. Becker | W. Berdel | A. M. Ilea